WCEI - Blog » osteomyelitis

Understanding Osteomyelitis: Challenges in Diagnosis & Treatment (Advanced)

Drew Griffin — Wed, 17 Aug 2011 08:00:09 +0000

Understanding Osteomyelitis: Challenges in Diagnosis & Treatment will be presented by Joseph Garner MD, Director, Division of Infectious Diseases, Hospital of Central Connecticut and Leslie Scoutt MD, Yale University School of Medicine at this year’s Wild on Wound’s National Conference in Las Vegas from September 7-10, 2011 .

This session will review salient features of the pathophysiology of bone infection, including mechanisms of infection and host responses. Significant time will be devoted to diagnosis, with an emphasis on imaging modalities. Bone infections are among the most difficult infections to cure and the principles of rational therapy will be presented.

For more information about the Wound Care Education Institute, please visit http://www.wcei.net.

Click Here To Register for the Wild on Wounds National Conference

Arobella Medical Presented at the Wild on Wounds Conference 2009 in Las Vegas NV

Drew Griffin — Mon, 21 Sep 2009 00:58:04 +0000

WCEI caught up with Charlie of Arobella Medical at the recent Wild on Wounds Conference in Las Vegas NV, held at The Paris Hotel. Charlie was able to give us a brief demonstration of the Qoustic System by Arobella Medical. Below is a short clip and demonstration of the Qoustic System by Arobella Medical.

For more information about the Qoustic System, please visit http://www.arobella.com

Qoustic Wound Therapy System™

For wounds, burns and hard & soft tissues
Overview:

Arobella Medical, LLC is an innovative company committed to providing wound care professionals with sophisticated technology to manage today’s most difficult cases.

The Qoustic Wound Therapy System™, patented and patent pending, uses ultrasonic energy for the selective dissection and fragmentation of tissues, wound debridement (acute and chronic wounds, burns, diseased or necrotic tissue) and cleansing saline irrigation of the site for the removal of debris, exudates, fragments, and other matter. Not only does the Qoustic Wound Therapy System™ provide a superior debriding process, but it also allows for more control over the procedure. The unique domed shape of the Qoustic Qurette™ significantly advances state-of-the-art technology by permitting controlled volumetric removal of unwanted tissue while focusing ultrasonic energy directly on the area of the wound being treated.

The Qoustic Wound Therapy System™ allows:

* Selective, precise, and gentle fragmentation of soft and hard tissues
* Preservation of healthy tissue through ultrasonic separation of damaged tissue
* Cleansing of the wound area with less pressure and pain
* Reduction of splash created by residuals of sharp debridement and saline wash
* Improvement in granulation of treated tissue
* Stable delivery of ultrasound energy during procedure

Recommended treatment:

This process is directed for single (1) treatment, and total recommended treatment shall be no more than three (3) times per week; typically treatment regimen is approximately two (2) weeks or more, depending on the size and nature/condition of the treated area as well as other subject dependent factors, but may be prescribed longer on the order of a physician.
Basic Information:

* This product has been cleared by the FDA for sale in the United States. Cleared indications for use (K062544)
o Selective dissection and fragmentation of tissue, wound debridement (acute and chronic wounds, burns, diseased or necrotic tissue), and cleansing irrigation of the site for the removal of debris, exudates, fragments, and other matter.
* Patent Pending
* Ideal for
o Wound Management
o Treating specific types of wounds including:
+ Diabetic foot ulcers
+ Pressure ulcers
+ Venous Insufficiency Ulcers
+ Arterial Wounds
+ Compromised Surgical Wounds
+ Burns
+ Osteomyelitis
+ Fistulas
+ Infected, Eczematous, Ulcerated or Devitalized Skin

Hyperbaric Oxygen Therapy (HBOT)

Drew Griffin — Mon, 04 May 2009 11:35:05 +0000

As an adjunctive therapy, Hyperbaric Oxygen Therapy is one that holds a lot of promise. The therapy consists of a person entering a chamber, either a monoplace (one person) or multiplace chamber (many people) and breathing nearly 100% oxygen at a pressure greater than sea level for a prescribed amount of time. A patient is typically “at pressure” for ninety (90) minutes. The patient is usually in the chamber for a total of about two (2) hours, since it takes approximately 9-16 minutes to get ‘down’ to therapeutic pressure and the same amount of time to ‘come back up’ to sea level pressure.

The goal of Hyperbaric Oxygen Therapy (HBOT) is to increase the amount of pressure and dissolved oxygen that is delivered to the body tissues. The pressure lends assistance to significantly increase tissue oxygenation in hypoperfused, or infected wounds.

HBOT is typically indicated for compromised wounds that are Diabetic Wagner Grade III, Acute Arterial Insufficiency, Gas Gangrene, Osteomyelitis (Failed convention wound therapy and s/p antibiotic therapy), compromised flaps and grafts, and osteoradionecrosis or effects of radiation. Here are some interesting case studies.

For more information about wound care and WCEI’s Wound Care Certification course click here